State-Level Transgender-Specific Policies, Race/Ethnicity, and Use of Medical Gender Affirmation Services among Transgender and Other Gender-Diverse People in the United States.
Adolescent
Adult
Aged
Aged, 80 and over
Ethnicity
/ statistics & numerical data
Female
Health Policy
Health Services Accessibility
/ legislation & jurisprudence
Humans
Insurance Coverage
/ legislation & jurisprudence
Insurance, Health
/ legislation & jurisprudence
Male
Middle Aged
Patient Acceptance of Health Care
/ statistics & numerical data
Racial Groups
/ psychology
Sexual and Gender Minorities
/ legislation & jurisprudence
State Government
Transgender Persons
/ legislation & jurisprudence
United States
Young Adult
Transgender
health care
hormone treatment
intersectionality
medical gender affirmation
policies
stigma
therapy
Journal
The Milbank quarterly
ISSN: 1468-0009
Titre abrégé: Milbank Q
Pays: United States
ID NLM: 8607003
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
pubmed:
19
8
2020
medline:
28
11
2020
entrez:
19
8
2020
Statut:
ppublish
Résumé
Policy Points Protective transgender-specific policies (including those related to experiences of discrimination, health insurance coverage, and changing legal documents) are associated with increased access to medical gender affirmation services (hormone treatment, therapy/counseling) for transgender and other gender-diverse people. Restrictive transgender-specific policies are associated with less access to these services. The relationship between race/ethnicity and use of medical gender affirmation services varies across states and is context specific, indicating that race/ethnicity also plays a role in access to these types of care across states. Advocacy is needed to prevent or overturn restrictive policies and promote protective policies for transgender and other gender-diverse people, especially for people of color. In the 2010s, the number of federal, state, and local transgender-specific policies increased. Some of these policies advanced protections for transgender and other gender-diverse (TGGD) people, and others were restrictive. Little is known about the relationships between these policies and use of medical gender affirmation services (eg, hormone treatment, therapy/counseling), or about how these associations may vary among different racial and ethnic groups. Multilevel modeling was used to examine the associations between state-level transgender-specific policies and the use of medical gender affirmation services among TGGD people in the United States. Data are from the 2015 U.S. Trans Survey of nearly 28,000 TGGD people. The medical gender affirmation services examined in this study were hormone treatment and therapy/counseling. The state policies we analyzed addressed discrimination, health insurance coverage, and changing legal documents; these policies were measured individually and as a composite index. Race/ethnicity was included in the multilevel regression models as a random slope to determine whether the relationship between race/ethnicity and the use of medical gender affirmation services varied by state. Individual policies and the policy index were associated with both outcomes (use of therapy/counseling and hormone treatment services), indicating that protective policies were associated with increased care. Broad religious exemption laws and Medicaid policies that excluded transgender-specific care were both associated with less use of therapy/counseling, whereas transgender-care-inclusive Medicaid policies were associated with more use of therapy/counseling. Nondiscrimination protections that include gender identity were associated with increased use of hormone treatment services. The relationship between race/ethnicity and medical gender affirmation services varied across states. State-level transgender-specific policies influence medical gender affirmation service use and seem to affect use by non-Hispanic white TGGD people and TGGD people of color differently. Advocacy is needed to repeal restrictive policies and promote protective policies in order to reduce health inequities among TGGD people, especially people of color.
Identifiants
pubmed: 32808696
doi: 10.1111/1468-0009.12467
pmc: PMC7482380
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
802-846Subventions
Organisme : NICHD NIH HHS
ID : P2C HD041028
Pays : United States
Organisme : NICHD NIH HHS
ID : P2C HD050924
Pays : United States
Organisme : NICHD NIH HHS
ID : T32 HD007168
Pays : United States
Informations de copyright
© 2020 Milbank Memorial Fund.
Références
J Adolesc Health. 2016 Sep;59(3):254-261
pubmed: 27235374
Transgend Health. 2016 Dec 01;1(1):279-290
pubmed: 28861542
Soc Sci Med. 2015 Dec;147:222-31
pubmed: 26599625
Health Aff (Millwood). 2016 Jun 1;35(6):1130-5
pubmed: 27193027
Ann Fam Med. 2007 Nov-Dec;5(6):492-502
pubmed: 18025486
Health Psychol. 2016 Sep;35(9):987-95
pubmed: 27175576
Behav Med. 2015;41(3):164-71
pubmed: 26287284
LGBT Health. 2017 Aug;4(4):244-247
pubmed: 28708447
Public Health Rep. 2001;116 Suppl 1:216-22
pubmed: 11889287
PLoS Med. 2011 Nov;8(11):e1001124
pubmed: 22131907
J Acquir Immune Defic Syndr. 2016 Aug 15;72 Suppl 3:S210-9
pubmed: 27429185
Demography. 2000 May;37(2):139-54
pubmed: 10836173
Am J Public Health. 2009 Apr;99(4):713-9
pubmed: 19150911
Women Health. 2014;54(8):750-67
pubmed: 25190135
Sex Res Social Policy. 2018 Mar;15(1):48-59
pubmed: 29527241
Transgend Health. 2018 Dec 26;3(1):220-224
pubmed: 30596149
Transgend Health. 2016 Jan;1(1):21-31
pubmed: 27595141
Psychol Med. 2002 Aug;32(6):959-76
pubmed: 12214795